PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment by Cross, Gail B., Sari, Intan P., Burkill, Sarah M., Yap, Chee Woei, Nguyen, Han, Quyet, Do, Dalay, Victoria B., Gutierrez, Emmanuel, Balanag, Vincent M., Castillo, Randy J., Chang, Christina C., Kelleher, Anthony D., O’Doherty, Jim, Paton, Nicholas I.

Get full text

Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial by Cross, Gail B, Sari, Intan P, Kityo, Cissy, Lu, Qingshu, Pokharkar, Yogesh, Moorakonda, Rajesh B, Thi, Han-Nguyen, Do, Quyet, Dalay, Victoria B, Gutierrez, Emmanuel, Balanag, Vincent M, Castillo, Randy J, Mugerwa, Henry, Fanusi, Felic, Kwan, Philip, Chew, Ka Lip, Paton, Nicholas I, Kityo, Cissy, Mugerwa, Henry, Tumukunde, Dinah, Akol, Joseph, Quyet, Do, Nguyen, Han, Hoang, Xuan Su, Doan, Thu Ha, Dalay, Victoria, Gutierrez, Emmanuel, Balanag, Vincent, Castillo, Randy Joseph, Barcelo, Monica, Veto, Rholine Gem Martin S., Baliwagan, Maria Begonia R., Balane, Glenn, Geronimo, Anthony, Flores, Rupert Rey, Pokharkar, Yogesh, Moorakonda, Rajesh Babu, Lu, Qingshu, Ng, Xuanhui, Tan, Shanice, Paton, Nicholas Iain, Cross, Gail Brenda, Sari, Intan Permata, Chew, Ka Lip, Fanusi, Felic, Kwan, Philip, Kelleher, Anthony Dominic, Chang, Christina

Get full text